Seeking Alpha

Illumina (ILMN -32.8%) is crushed following its Q3 warning. Citi, which smartly downgraded...

Illumina (ILMN -32.8%) is crushed following its Q3 warning. Citi, which smartly downgraded shares in advance, is slashing its PT to $32, arguing Illumina's growth trajectory is now "called into question." Auriga is maintaining a Buy, citing Illumina's position in the next-gen DNA sequencing market. In addition to Life Sciences (LIFE -5.5% - previously), Affymetrix (AFFX -5.5%) is selling off on the news.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|